Therapy News and Research

RSS

Breast cancer‐on‐a‐chip to test the effectiveness of checkpoint inhibitor drugs

There are many mechanisms by which the body responds to foreign invaders. One of these involves the T-cells of the immune system, which have a number of different proteins on their surface called "checkpoint proteins."

2 Feb 2021

Yale scientists develop an injection-based therapy for skin cancer

Yale researchers are developing a skin cancer treatment that involves injecting nanoparticles into the tumor, killing cancer cells with a two-pronged approach, as a potential alternative to surgery.

2 Feb 2021

Immune dysregulation can affect the efficacy of CAR T therapy in some lymphoma patients

Chimeric antigen receptor T-cell therapy, or CAR T, has been a breakthrough in the treatment of blood cancers such as acute lymphoblastic leukemia and diffuse large B-cell lymphoma.

2 Feb 2021

CoCID project aims to develop soft X-ray microscope for visualizing cellular origin of diseases

CoCID (Compact Cell Imaging Device), a €5.7 million, four-year, pan-European research and innovation project, funded through Horizon 2020, has officially commenced.

2 Feb 2021

Study identifies triggers for acute decompensation of liver cirrhosis

Chronic liver disease and even cirrhosis can go unnoticed for a long time because many patients have no symptoms: the liver suffers silently.

2 Feb 2021

Scientists discover potential drug target for Hutchinson-Gilford progeria syndrome

New study describes a potential drug target for Hutchinson-Gilford progeria syndrome that may aid in the development of more effective treatments.

2 Feb 2021

Zinc supplementation bolsters repurposed antivirals against SARS-CoV-2

A new preprint reports the efficacy of two repurposed drugs that could be useful against SARS-CoV-2 when supplemented with zinc.

2 Feb 2021

Could ultra-low dose radiotherapy treat COVID-19-related pneumonia?

Researchers at the Department of Radiation Oncology, La Milagrosa Hospital, GenesisCare, Madrid, Spain, showed the potential benefit of treating COVID-19 pneumonia with ultra-low doses of radiotherapy.

2 Feb 2021

Albumin: The Natural Choice for Diagnostic Tests

The availability of established diagnostic kits has enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Such technologies took decades to optimize, but they are now playing an important role in identifying and managing the spread of COVID-19. Recombumin® provides an enhanced solution as part of this toolbox for dealing with this disease

From Albumedix Ltd. 2 Feb 2021

Albumedix enters into collaboration agreement with Cell and Gene Therapy Catapult

Albumedix Ltd. (‘Albumedix’), an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.

From Albumedix Ltd. 2 Feb 2021

Research shows a promising alternative to personalized deep brain stimulation

Millions of patients suffering from neurological and mental disorders such as depression, addiction, and chronic pain are treatment-resistant. In fact, about 30% of all major depression patients do not respond at all to any medication or psychotherapy.

2 Feb 2021

Updated concussion guidelines reduced length of symptoms among athletes

The adoption of recommended changes in concussion management led to a reduction in the length of symptoms among 11- to 18-year-old athletes with first-time, sports-related concussions, according to new research in the Journal of Osteopathic Medicine.

2 Feb 2021

New protein acts as trickster to neutralize COVID-19 infection in human kidney organoid

Decoy protein intercepts spike of coronavirus. Virus prevented from infecting human cells. Protein may be a new way to treat and prevent COVID-19.

1 Feb 2021

WHO recommends dapivirine vaginal ring as additional HIV prevention choice for at-risk women

WHO today recommended that the dapivirine vaginal ring (DPV-VR) may be offered as an additional prevention choice for women at substantial risk of HIV infection as part of combination prevention approaches.

1 Feb 2021

An integrated approach could pave the way for future control of Alzheimer's disease

This new pioneering study by Prof. Ricardo Maccioni and coworkers of the International Center for Biomedicine, "New Frontiers in the prevention, diagnosis and treatment of Alzheimer´s disease" was published in the special issue of Latin American investigators of the Journal of Alzheimer's Disease.

1 Feb 2021

New WHO guidelines provide recommendations for managing chronic pain in children

Chronic pain or pain that persists or recurs for longer than three months in children is a significant public health problem and a leading cause of morbidity in children globally.

1 Feb 2021

Life-threatening genetic immunodeficiency reversed by a rare DNA change

Researchers have revealed how a rare DNA change rebalanced the immune system of patients with a life-threatening genetic immunodeficiency.

1 Feb 2021

Groundbreaking therapy may provide a new treatment modality for biofilm infections in foot ulcers

A new £1.7m project to explore using plasma jets and antimicrobial dressings to treat debilitating - and potentially deadly - wound infections launches today.

1 Feb 2021

Study finds high bleeding risk in a sub-group of COVID-19 patients

The human body strives to keep itself in homeostasis, or balance. When blood clots are created, the body's innate response is to break the clots down to prevent significant health problems from arising.

1 Feb 2021

Phase III study of (m)RNA expression did not confer significant advantage for stage II-III lung cancer

A phase III study examining whether messenger (m)RNA expression correlated with sensitivity or resistance to chemotherapy did not confer a statistically significant advantage in overall survival for patients with resected stage II-III non-small cell lung cancer (NSCLC), according to research presented at the International Association for the Study of Lung Cancer World Conference on Lung Cancer.

31 Jan 2021

Therapy News and Research

Breast cancer‐on‐a‐chip to test the effectiveness of checkpoint inhibitor drugs

Yale scientists develop an injection-based therapy for skin cancer

Immune dysregulation can affect the efficacy of CAR T therapy in some lymphoma patients

CoCID project aims to develop soft X-ray microscope for visualizing cellular origin of diseases

Study identifies triggers for acute decompensation of liver cirrhosis

Scientists discover potential drug target for Hutchinson-Gilford progeria syndrome

Zinc supplementation bolsters repurposed antivirals against SARS-CoV-2

Could ultra-low dose radiotherapy treat COVID-19-related pneumonia?

Albumin: The Natural Choice for Diagnostic Tests

Albumedix enters into collaboration agreement with Cell and Gene Therapy Catapult

Research shows a promising alternative to personalized deep brain stimulation

Updated concussion guidelines reduced length of symptoms among athletes

New protein acts as trickster to neutralize COVID-19 infection in human kidney organoid

WHO recommends dapivirine vaginal ring as additional HIV prevention choice for at-risk women

An integrated approach could pave the way for future control of Alzheimer's disease

New WHO guidelines provide recommendations for managing chronic pain in children

Life-threatening genetic immunodeficiency reversed by a rare DNA change

Groundbreaking therapy may provide a new treatment modality for biofilm infections in foot ulcers

Study finds high bleeding risk in a sub-group of COVID-19 patients

Phase III study of (m)RNA expression did not confer significant advantage for stage II-III lung cancer

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News